Axcan to acquire Mpex, gaining Phase III candidate aerosol antibiotic for CF patients
15 April 2011
Nancy Faigen
Please Login to read the full article.
15 April 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Rib-X Pharma files for IPO to finance antibiotics providing superior coverage
- Insmed plummets on FDA prolonged hold on Arikace programme
- Aptalis gains double win from US FDA for pancreatic enzymes
- Breaking out of a clinical hold, Insmed to enrol into two late-stage trials for lung disease
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
